Rallybio Corp
Pharmaceutical company · New Haven, Connecticut, United States · Nasdaq: RLYB
Rallybio Corp is a pharmaceutical company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker RLYB. It has reported private securities offerings to the US SEC, most recently $6.6 million sold in a notice filed in 2024.
Rallybio at a glance
What does Rallybio do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $6.6 million sold (2024).
Frequently asked questions about Rallybio
Where is Rallybio headquartered?
Rallybio Corp is headquartered in New Haven, Connecticut, United States.
What does Rallybio do?
Rallybio Corp is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Rallybio a public company?
Yes. Rallybio Corp trades on Nasdaq under the ticker RLYB.
When was Rallybio founded?
The earliest incorporation on record for Rallybio Corp is in 2018, according to public company registers.
Similar companies
- Arvinas, Inc.New Haven, Connecticut, United States
- Yarrow Bioscience, Inc.New Haven, Connecticut, United States
- Trevi Therapeutics, Inc.New Haven, Connecticut, United States
- Veradermics, IncNew Haven, Connecticut, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.